Submit  |   Chinese  | 
Advanced Search
   Home  |  Online Now  |  Current Issue  |  Focus  |  Archive  |  For Authors  |  Journal Information   Open Access  
Submit  |   Chinese  | 
[Online] Pharmaceutical Engineering

Guest Editor-in-Chief
Yang, Baofeng, Harbin Medical University, China
Associate Editors
Chen, Zhinan, Fourth Military Medical University, China
Ganser, Arnold, Hannover Medical School, Germany
Ding, Jian, Shanghai Institute of Materia Medica, CAS, China
Fu, Xiaobing, General Hospital of PLA, China
Hoyer, Daniel, Melbourne Medical School, Australia
Huang, Luqi, National Resources Center for Chinese Materia Medica, CAS, China
Li, Ren-Ke, Toronto Medical Discovery Tower, Canada
Li, Song, Beijing Institute of Pharmacology and Toxicology, China
Nattel, Stanley, University of Montreal, Canada
Vanhoutte, Paul M., Hong Kong University, China
Zhang, Boli, China Academy of Chinese Medical Sciences, China
Default Latest Most Read
Please wait a minute...
For Selected: View Abstracts Toggle Thumbnails
Application of Biomaterials in Cardiac Repair and Regeneration
Zhi Cui,Baofeng Yang,Ren-Ke Li
Engineering    2016, 2 (1): 141-148.
Abstract   HTML   PDF (771KB)

Cardiovascular disease is a leading cause of death throughout the world. The demand for new therapeutic interventions is increasing. Although pharmacological and surgical interventions dramatically improve the quality of life of cardiovascular disease patients, cheaper and less invasive approaches are always preferable. Biomaterials, both natural and synthetic, exhibit great potential in cardiac repair and regeneration, either as a carrier for drug delivery or as an extracellular matrix substitute scaffold. In this review, we discuss the current treatment options for several cardiovascular diseases, as well as types of biomaterials that have been investigated as potential therapeutic interventions for said diseases. We especially highlight investigations into the possible use of conductive polymers for correcting ischemic heart disease-induced conduction abnormalities, and the generation of biological pacemakers to improve the conduction pathway in heart block.

Table and Figures | Reference | Related Articles | Metrics
Tumor Molecular Imaging with Nanoparticles
Zhen Cheng,Xuefeng Yan,Xilin Sun,Baozhong Shen,Sanjiv Sam Gambhir
Engineering    2016, 2 (1): 132-140.
Abstract   HTML   PDF (2399KB)

Molecular imaging (MI) can provide not only structural images using traditional imaging techniques but also functional and molecular information using many newly emerging imaging techniques. Over the past decade, the utilization of nanotechnology in MI has exhibited many significant advantages and provided new opportunities for the imaging of living subjects. It is expected that multimodality nanoparticles (NPs) can lead to precise assessment of tumor biology and the tumor microenvironment. This review addresses topics related to engineered NPs and summarizes the recent applications of these nanoconstructs in cancer optical imaging, ultrasound, photoacoustic imaging, magnetic resonance imaging (MRI), and radionuclide imaging. Key challenges involved in the translation of NPs to the clinic are discussed.

Table and Figures | Reference | Related Articles | Metrics
Nitroxyl, a New Generation of Positive Inotropic Agent for Heart Failure
Ye Tian, Nazareno Paolocci, Wei Dong Gao
Engineering    2015, 1 (4): 401-404.
Abstract   HTML   PDF (186KB)
Reference | Related Articles | Metrics
Cardiac Remote Conditioning and Clinical Relevance: All Together Now!
Kristin Luther,Yang Song,Yang Wang,Xiaoping Ren,W. Keith Jones
Engineering    2015, 1 (4): 490-499.
Abstract   HTML   PDF (750KB)

Acute myocardial infarction (AMI) is the leading cause of death and disability worldwide. Timely reperfusion is the standard of care and results in decreased infarct size, improving patient survival and prognosis. However, 25% of patients proceed to develop heart failure (HF) after myocardial infarction (MI) and 50% of these will die within five years. Since the size of the infarct is the major predictor of the outcome, including the development of HF, therapies to improve myocardial salvage have great potential. Over the past three decades, a number of stimuli have been discovered that activate endogenous cardioprotective pathways. In ischemic preconditioning (IPC) and ischemic postconditioning, ischemia within the heart initiates the protection. Brief reversible episodes of ischemia in vascular beds remote from the heart can also trigger cardioprotection when applied before, during, or immediately after myocardial ischemia—known as remote ischemic pre-, per-, and post-conditioning, respectively. Although the mechanism of remote ischemic preconditioning (RIPC) has not yet been fully elucidated, many mechanistic components are shared with IPC. The discovery of RIPC led to research into the use of remote non-ischemic stimuli including nerve stimulation (spinal and vagal), and electroacupuncture (EA). We discovered and, with others, have elucidated mechanistic aspects of a non-ischemic phenomenon we termed remote preconditioning of trauma (RPCT). RPCT operates via neural stimulation of skin sensory nerves and has similarities and differences to nerve stimulation and EA conducted at acupoints. We show herein that RPCT can be mimicked using electrical stimulation of the abdominal midline (EA-like treatment) and that this modality of activating cardioprotection is powerful as both a preconditioning and a postconditioning stimulus (when applied at reperfusion). Investigations of these cardioprotective phenomena have led to a more integrative understanding of mechanisms related to cardioprotection, and in the last five to ten years, it has become clear that the mechanisms are similar, whether induced by ischemic or non-ischemic stimuli. Taking together much of the data in the literature, we propose that all of these cardioprotective “conditioning” phenomena represent activation from different entry points of a cardiac conditioning network that converges upon specific mediators and effectors of myocardial cell survival, including NF-кB, Stat3/5, protein kinase C, bradykinin, and the mitoKATP channel. Nervous system pathways may represent a novel mechanism for initiating conditioning of the heart and other organs. IPC and RIPC have proven difficult to translate clinically, as they have associated risks and cannot be used in some patients. Because of this, the use of neural and nociceptive stimuli is emerging as a potential non-ischemic and non-traumatic means to initiate cardiac conditioning. Clinical relevance is underscored by the demonstration of postconditioning with one of these modalities, supporting the conclusion that the development of pharmaceuticals and electroceuticals for this purpose is an area ripe for clinical development.

Table and Figures | Reference | Related Articles | Metrics
Conjugation with Acridines Turns Nuclear Localization Sequence into Highly Active Antimicrobial Peptide
Wei Zhang,Xiaoli Yang,Jingjing Song,Xin Zheng,Jianbo Chen,Panpan Ma,Bangzhi Zhang,Rui Wang
Engineering    2015, 1 (4): 500-505.
Abstract   HTML   PDF (4096KB)

The emergence of multidrug-resistant bacteria creates an urgent need for alternative antibiotics with new mechanisms of action. In this study, we synthesized a novel type of antimicrobial agent, Acr3-NLS, by conjugating hydrophobic acridines to the N-terminus of a nuclear localization sequence (NLS), a short cationic peptide. To further improve the antimicrobial activity of our agent, dimeric (Acr3-NLS)2 was simultaneously synthesized by joining two monomeric Acr3-NLS together via a disulfide linker. Our results show that Acr3-NLS and especially (Acr3-NLS)2 display significant antimicrobial activity against gram-negative and gram-positive bacteria compared to that of the NLS. Subsequently, the results derived from the study on the mechanism of action demonstrate that Acr3-NLS and (Acr3-NLS)2 can kill bacteria by membrane disruption and DNA binding. The double targets–cell membrane and intracellular DNA–will reduce the risk of bacteria developing resistance to Acr3-NLS and (Acr3-NLS)2. Overall, this study provides a novel strategy to design highly effective antimicrobial agents with a dual mode of action for infection treatment.

Table and Figures | Reference | Related Articles | Metrics
Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
Anne H. Schmieder,Shelton D. Caruthers,Jochen Keupp,Samuel A. Wickline,Gregory M. Lanza
Engineering    2015, 1 (4): 475-489.
Abstract   HTML   PDF (2072KB)

The research roots of 19fluorine (19F) magnetic resonance imaging (MRI) date back over 35 years. Over that time span, 1H imaging flourished and was adopted worldwide with an endless array of applications and imaging approaches, making magnetic resonance an indispensable pillar of biomedical diagnostic imaging. For many years during this timeframe, 19F imaging research continued at a slow pace as the various attributes of the technique were explored. However, over the last decade and particularly the last several years, the pace and clinical relevance of 19F imaging has exploded. In part, this is due to advances in MRI instrumentation, 19F/1H coil designs, and ultrafast pulse sequence development for both preclinical and clinical scanners. These achievements, coupled with interest in the molecular imaging of anatomy and physiology, and combined with a cadre of innovative agents, have brought the concept of 19F into early clinical evaluation. In this review, we attempt to provide a slice of this rich history of research and development, with a particular focus on liquid perfluorocarbon compound-based agents.

Table and Figures | Reference | Related Articles | Metrics
First page | Prev page | Next page | Last page Page 1 of 1, 6 articles found  
Current Issue
Volume 4 • Issue 4 •
· News & Highlights
· Views & Comments
· Editorial
· Topic Insights
· Research
Table of Contents
Most Popular
Most Read
Most Download
Most Cited

Copyright © 2015 Higher Education Press & Engineering Sciences Press, All Rights Reserved.